Safety and efficacy profile of S-005151 (Redasemtide), in patients with chronic liver diseases: phase 2 trial. - Tsuchiya A; Watanabe Y; Kimura N; Abe H; Setsu T; Yokoo T; Kamimura H; Sakamaki A; Saito H; Tominaga M; Sato T; Kitamura N; et al. (Inflammation and regeneration, 2026)